| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |